GlassScriptPhysician profile
Thomas Jackson Thomasson
NPI 1962603084
$2,681.86
in general payments reported to CMS, 2019-2025
17 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $270 · 2021: $285 · 2022: $536 · 2023: $397 · 2024: $444 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,216.95 | 2021-2025 | Dynacord, Healix Knotless Peek, Dynatape |
| Pacira Therapeutics, INC. | $324.76 | 2019-2021 | |
| Horizon Therapeutics Plc | $174.86 | 2019-2021 | |
| Prime Surgical, LLC | $156.15 | 2024 | |
| Bioventus LLC | $135.74 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Sanara Medtech INC. | $125.17 | 2023 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $106.30 | 2023-2024 | Zilretta, Exparel, Iovera |
| Sanofi-Aventis U.S. LLC | $97.68 | 2019-2023 | |
| Smith+Nephew, INC. | $71.98 | 2023 | Journey II, Pico 14 |
| Stryker Corporation | $70.08 | 2021-2025 | Augment Injectable |
| Zimmer Biomet Holdings, INC. | $47.27 | 2023 | Persona |
| Pfizer INC. | $37.87 | 2020 | |
| Convatec INC. | $34.29 | 2020-2024 | |
| Medical Device Business Services, INC. | $32.56 | 2021 | |
| Si-Bone, INC. | $18.99 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $15.86 | 2021 | |
| Orthofix Medical, INC. | $15.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Thomasson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.